<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17120" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Actinic Cheilitis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Muse</surname>
            <given-names>Mikel E.</given-names>
          </name>
          <aff>Campbell</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Crane</surname>
            <given-names>Jonathan S.</given-names>
          </name>
          <aff>Sampson Regional Med Ctr / Campbell Univ</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mikel Muse declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jonathan Crane declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>31</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17120.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Actinic cheilitis is a precancerous lesion that forms most commonly on the lower lip. Similar to actinic keratosis, actinic cheilitis can undergo malignant transformation leading to squamous cell carcinoma (SCC). SCC on the lips is 11 times as likely to metastasize compared to SCC found on other parts of the body. This activity outlines the evaluation and management of actinic cheilitis, a premalignant lesion found on the lips and highlights the role of the healthcare providers in evaluating and managing patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of actinic cheilitis.</p></list-item><list-item><p>Review the evaluation of actinic cheilitis.</p></list-item><list-item><p>Outline the treatment and management options available for actinic cheilitis.</p></list-item><list-item><p>Describe interprofessional team strategies for improving care coordination and communication to improve outcomes for patients with actinic cheilitis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17120&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17120">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17120.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>&#x0201c;Sailor&#x02019;s Lip,&#x0201d; or actinic cheilitis (AC), is a precursor of squamous cell carcinoma (SCC) found on the lips. Similar to actinic keratosis, actinic cheilitis is a premalignant lesion caused by chronic sun exposure. It is most common on the lower lip along the vermillion border. Given SCC on the lips is considered a high-risk form of skin cancer with an 11% chance of metastasis compared to 1% for other body locations, it is essential to recognize and appropriately manage these potentially malignant precursory lesions.<xref ref-type="bibr" rid="article-17120.r1">[1]</xref></p>
      </sec>
      <sec id="article-17120.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Actinic cheilitis results from the sun or UV radiation exposure. Additional risk factors include increased age, especially over 60 years, Fitzpatrick I and II skin types, genetic abnormalities affecting pigmentation such as albinism, working more than 25yrs outdoors, or a history of nonmelanoma skin cancer (NMSC). There has been conflicting evidence as to whether alcohol and smoking independently increase the risk of AC.<xref ref-type="bibr" rid="article-17120.r2">[2]</xref></p>
      </sec>
      <sec id="article-17120.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The prevalence of&#x000a0;actinic cheilitis is higher among fair-skinned populations and those closer to the equator where there is more UV exposure. Men are affected more than women, likely due to their comparatively increased work in the sun and less use of protective lip balm and cosmetics. The exact prevalence of AC is unknown, as the majority of data focuses on the incidence of SCC. In the US, there are more than 3500 new cases of lip cancer annually, 90% are SCC.<xref ref-type="bibr" rid="article-17120.r3">[3]</xref><xref ref-type="bibr" rid="article-17120.r4">[4]</xref>&#x000a0;A recent study showed the prevalence of AC in the population over age 45 years old to be 31.3% in northwestern Spain.<xref ref-type="bibr" rid="article-17120.r5">[5]</xref></p>
      </sec>
      <sec id="article-17120.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Those with fair skin have less melanin and innately less protection against UV rays. The physical properties of the lips, such as their shape and being a transition area from oral mucosa to skin with thinner epithelium, less sebaceous glands, and less melanin, contribute to less protection and increased exposure to UV radiation. Chronic exposure to UV light damages tumor suppressor gene p53 resulting in uncontrolled replication of defective cells, which is a common gene mutation found with increasing frequency as actinic cheilitis and actinic keratoses undergo malignant transformation to SCC. Although actinic cheilitis can affect both the upper and lower oral cutaneous mucosa, more light from the sun hits the lower lip, making this area especially prone to sun damage and an increased number of skin cancers.<xref ref-type="bibr" rid="article-17120.r6">[6]</xref></p>
      </sec>
      <sec id="article-17120.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Biopsy w/ H&#x00026;E is recommended for persistent suspicious lip lesions to rule out invasive skin cancer. Basic histopathology for actinic cheilitis would be:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Hyperkeratosis</bold><bold>:</bold> thickening of stratum corneum</p>
          </list-item>
          <list-item>
            <p><bold>Solar elastosis:</bold> &#x000a0;loss of eosin staining, accumulation of irregular thick elastic fibers and tangled fibrillin</p>
          </list-item>
          <list-item>
            <p><bold>Epithelial dysplasia (mild-moderate</bold>): disordered maturation of epidermal cells, loss of rete ridges, variable cytological atypia</p>
          </list-item>
          <list-item>
            <p><bold>Perivascular inflammation:</bold> inflammatory cells around the blood vessels</p>
          </list-item>
          <list-item>
            <p><bold>Severe dysplasia:</bold> increase in dyskeratosis, keratin pearls, drop-shaped projections, and nuclei related changes such as mitoses and pleomorphism indicate the progression of dysplasia and increased malignant transformation.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17120.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <list list-type="bullet">
          <list-item>
            <p>Persistent white plaque with &#x0201c;sandpapery&#x0201d; feel on the lips</p>
          </list-item>
          <list-item>
            <p>Most commonly lower lip</p>
          </list-item>
          <list-item>
            <p>Blurring of the vermillion border between the cutaneous and mucosal lip</p>
          </list-item>
          <list-item>
            <p>Usually asymptomatic/painless, but may have burning, numbness, pain</p>
          </list-item>
          <list-item>
            <p>Eventually, plaque may become indurated, scaly and ulcerate as lesion progresses</p>
          </list-item>
          <list-item>
            <p>Outdoor laborers: sailors, farmers, construction workers, lifeguards</p>
          </list-item>
          <list-item>
            <p>Fitzpatrick I-II fair-skinned individuals</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17120.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Actinic cheilitis is a diagnosis made from clinical and histopathology evaluation. It is essential to distinguish between cheilitis (benign inflammation),&#x000a0; premalignant actinic cheilitis, and squamous cell carcinoma. Skin biopsy is the golden standard regarding the evaluation of a persistent suspicious lesion on the lip. Many lesions initially thought to be premalignant actinic cheilitis on exam were found to be SCC upon histological evaluation, which indicates providers are not able to entirely make the diagnosis clinically, and biopsy is helpful when evaluating these lesions. While not required to make a diagnosis, one article suggests evaluating patients with electron microscopy helps to assess further the ultrastructural changes found in AC lesions, their potential for malignant transformation, and ensure they are diagnosed and managed correctly.<xref ref-type="bibr" rid="article-17120.r7">[7]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Physical exam: persistent white/erythematous thickening sandpapery skin on the lower lip</p>
          </list-item>
          <list-item>
            <p>Labwork: for lesions that are new, symmetric, in young patients, found in&#x000a0;patient's with darker skin types, or individuals without a history of chronic sun exposure where skin cancer is less likely,&#x000a0;consider first ruling out reversible causes such as those with a vitamin deficiency/infectious/contact/irritant etiology (Chart 1)</p>
          </list-item>
          <list-item>
            <p>Skin biopsy: skin biopsy is recommended for persistent lesions</p>
          </list-item>
          <list-item>
            <p>Electron Microscopy:&#x000a0;hyperkeratosis, mild acanthosis, Perivascular lymphocytic infiltrate around glandular ducts</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17120.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of actinic cheilitis should depend on the size, location, and severity of the lesion, along with the patient&#x02019;s other comorbidities. The goal of therapy is to reduce the risk of malignant transformation from AC to SCC while maintaining functionality and cosmesis of the lips. A variety of therapies targeted at removing the dysplastic epithelium have been used to manage AC, including both surgical and medical options.</p>
        <p>Surgical/destructive options for treatment include excisional&#x000a0;vermilionectomy, cryotherapy, electrocautery, and pulse-dye or CO2 laser. However, these procedures are&#x000a0;invasive, and patients may experience adverse effects such as pain, delayed healing, infection, scarring, edema, and paresthesias.&#x000a0;</p>
        <p>Non-surgical&#x000a0;treatments for AC&#x000a0;include topical therapies such as 5-fluorouracil, imiquimod, trichloroacetic acid, ingenol mebutate, diclofenac, phototherapy, topical DNA enzyme repair creams, photoprotection, and curettage with methyl aminolevulinate cream/daylight PDT.<xref ref-type="bibr" rid="article-17120.r3">[3]</xref>&#x000a0;Many of the topical treatments cause adverse effects such as inflammation, crusting, and pain, which may reduce patient compliance.</p>
        <p>A systemic review and meta-analysis of 283 patients showed surgically treated lesions compared to medically managed lesions had a higher remission rate (92.8% vs. 65%) and lower recurrence rates (8.4 vs. 19.2%) than non-surgical treatment.<xref ref-type="bibr" rid="article-17120.r8">[8]</xref>&#x000a0;Dermoscopy has been used to aid with diagnosis and monitor treatment management in patients undergoing topical treatment.<xref ref-type="bibr" rid="article-17120.r9">[9]</xref></p>
        <p>It is difficult to directly compare efficacy across the numerous treatment options available for actinic cheilitis since many of the published studies, the severity of actinic cheilitis, and treatment regimens are not consistent or controlled across studies. However, the following options may be an option when deciding management for actinic cheilitis.&#x000a0;</p>
        <p>Summary of Treatment Options:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Laser treatment:</bold>
<bold>preferred non-surgical intervention</bold> (efficacy 93%, low recurrences)<xref ref-type="bibr" rid="article-17120.r10">[10]</xref>
<list list-type="bullet"><list-item><p>CO2 Laser: 10600 nm</p></list-item><list-item><p>Erbium Laser: 2940 nm</p></list-item><list-item><p>Adverse effects: pain, hypertrophic scarring (managed with corticosteroids)</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Vermilionectomy/Surgical excision:</bold> preferred treatment for <bold>severe/refractory cases</bold> (efficacy near 100%, low recurrences).<xref ref-type="bibr" rid="article-17120.r10">[10]</xref>
<list list-type="bullet"><list-item><p>Adverse effects: pain, delayed healing, infection, scarring, edema, paresthesias, may be cosmetically disfiguring compared to other treatment options</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Topical Treatments:</bold>&#x000a0;preferred treatment for patients with large areas of sun damage or those&#x000a0;<bold>preferring medical&#x000a0;intervention</bold>
<list list-type="bullet"><list-item><p>Various treatment regimens studied, examples range from applying&#x000a0;to affected area once daily for 1 to 4 weeks depending on patient's tolerability (Efficacy for 5-FU at one week 69%, increased to 91% efficacy at four weeks)&#x000a0;&#x000a0;</p></list-item><list-item><p>Adverse effects: pain, crusting, inflammation, reduced patient compliance</p></list-item><list-item><p>Summary of Topical Options and Their Mechanism of Action
<list list-type="bullet"><list-item><p>5-FU: impairs pyrimidine thymidine synthesis and DNA replication</p></list-item><list-item><p>Imiquimod: nucleoside analog and immunostimulator</p></list-item><list-item><p>Ingenol mebutate: induces cell death and neutrophil-mediated antibody-dependent immune response to clear tumors</p></list-item><list-item><p>Trichloroacetic acid: induces cell necrosis</p></list-item><list-item><p>Diclofenac: anti-inflammatory, induces apoptosis by inhibiting COX 1 and COX2</p></list-item></list>
</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Phototherapy:</bold> while actinic cheilitis results from by UV light damaging epithelial DNA, light therapy at an increased intensity level that causes reactive oxygen species to destroy damaged skin cells and was found to be an effective treatment in some cases (efficacy 68%,12% recurrences). Efficacy increases when&#x000a0;used in conjunction with other treatment options, including topical treatments.<xref ref-type="bibr" rid="article-17120.r10">[10]</xref>
<list list-type="bullet"><list-item><p>Adverse effects include pain, recurrence</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Cryotherapy:</bold> liquid nitrogen physically destroys abnormal cells
<list list-type="bullet"><list-item><p>Adverse effects include pain, crusting, scarring, reduced efficacy compared to other treatment options</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Electrocautery/Curettage:</bold> physical destruction of the abnormal cells
<list list-type="bullet"><list-item><p>Adverse effects include pain, scarring</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Photoprotection:</bold> reduce the progression
<list list-type="bullet"><list-item><p>&#x000a0;Dependent on patient compliance</p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17120.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Diagnoses to consider when evaluating a lesion on the lip include squamous cell carcinoma, basal cell carcinoma, malignant melanoma, herpes, leukoplakia, and a variety of forms of cheilitis. Cheilitis, or inflammation&#x000a0;affecting the lips, has a broad differential that can group into reversible, non-reversible, and systemic causes.<xref ref-type="bibr" rid="article-17120.r11">[11]</xref> (Chart 1)&#x000a0;Given the malignant potential of lesions on the lip, it may be helpful to obtain a skin biopsy if lesion persists and is refractory to treatment.</p>
      </sec>
      <sec id="article-17120.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Actinic cheilitis is a premalignant lesion, with the possibility of progression into SCC in 6 to 10% of cases. Patients with actinic cheilitis&#x000a0;should follow up after treatment with visits at least every six months for the first two years, and annual skin checks after that.<xref ref-type="bibr" rid="article-17120.r8">[8]</xref></p>
      </sec>
      <sec id="article-17120.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Reports are as high as 95% of SCC on the lip initially starting as actinic cheilitis. SCC on the lip is much more dangerous than SCC other parts of the body, with 11% of SCC lip lesions metastasizing compared to 1% of SCC found in other anatomical locations.<xref ref-type="bibr" rid="article-17120.r1">[1]</xref></p>
      </sec>
      <sec id="article-17120.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients can reduce their risks for actinic cheilitis and further malignant transformation of actinic cheilitis into SCC by:</p>
        <list list-type="bullet">
          <list-item>
            <p>Sunscreen and UV protective clothing</p>
          </list-item>
          <list-item>
            <p>Wide-brimmed hats</p>
          </list-item>
          <list-item>
            <p>Lip balms or makeup containing sunscreen/zinc</p>
          </list-item>
          <list-item>
            <p>Routine skin checks and follow-up&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-17120.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The anatomical location of actinic cheilitis on the lip is a location&#x000a0;managed by a variety of healthcare providers. Providers in dermatology, dentistry, ENT, and primary care must be aware of actinic cheilitis as a premalignant lesion. They should have a low threshold to biopsy persistent lesions on the lips, especially if the patient has fair skin, a history of sun exposure, or a history of skin cancer. Appropriate monitoring, treatment, and consistent follow up reduces the risk of malignant transformation of actinic cheilitis to SCC. All providers need to be aware and refer a patient if they are not certain of the nature of a lip lesion.</p>
      </sec>
      <sec id="article-17120.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17120&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17120">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/cancer/actinic-cheilitis-sailors-lip/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=17120">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17120/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17120">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-17120.s16">
        <fig id="article-17120.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Cheilitis Differential and Treatment Contributed by Mikel Muse, DO
Adapted from Liborija Lugovi&#x00107;-Mihi&#x00107;, Differential Diagnosis of Cheilitis (2018)</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Cheilitis__Chart" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-17120.s17">
        <fig id="article-17120.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Actinic cheilitis Image courtesy S Bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="actinic__cheilitis" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-17120.s18">
        <title>References</title>
        <ref id="article-17120.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barrado Sol&#x000ed;s</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mol&#x000e9;s Poveda</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lloret Ruiz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pont Sanjuan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Velasco Pastor</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Quecedo Est&#x000e9;banez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Miquel Miquel</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Ingenol mebutate gel treatment for actinic cheilitis: report of four cases.</article-title>
            <source>Dermatol Ther</source>
            <year>2015</year>
            <season>Mar-Apr</season>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>79</fpage>
            <page-range>79-82</page-range>
            <pub-id pub-id-type="pmid">25545762</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17120.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodr&#x000ed;guez-Blanco</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Fl&#x000f3;rez</surname>
                <given-names>&#x000c1;</given-names>
              </name>
              <name>
                <surname>Paredes-Su&#x000e1;rez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-Lojo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Vilas</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ram&#x000ed;rez-Santos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Paradela</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Conde</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Pereiro-Ferreir&#x000f3;s</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Actinic Cheilitis: Analysis of Clinical Subtypes, Risk Factors and Associated Signs of Actinic Damage.</article-title>
            <source>Acta Derm Venereol</source>
            <year>2019</year>
            <month>Sep</month>
            <day>01</day>
            <volume>99</volume>
            <issue>10</issue>
            <fpage>931</fpage>
            <page-range>931-932</page-range>
            <pub-id pub-id-type="pmid">31197386</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17120.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hodak</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Enk</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Snast</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Slodownik</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lapidoth</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Daylight photodynamic therapy for the treatment of actinic cheilitis.</article-title>
            <source>Photodermatol Photoimmunol Photomed</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>35</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-16</page-range>
            <pub-id pub-id-type="pmid">30066408</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17120.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boring</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Squires</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Tong</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Cancer statistics, 1993.</article-title>
            <source>CA Cancer J Clin</source>
            <year>1993</year>
            <season>Jan-Feb</season>
            <volume>43</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-26</page-range>
            <pub-id pub-id-type="pmid">8422609</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17120.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodr&#x000ed;guez-Blanco</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Fl&#x000f3;rez</surname>
                <given-names>&#x000c1;</given-names>
              </name>
              <name>
                <surname>Paredes-Su&#x000e1;rez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-Lojo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Vilas</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ram&#x000ed;rez-Santos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Paradela</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Su&#x000e1;rez Conde</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Pereiro-Ferreir&#x000f3;s</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Actinic Cheilitis Prevalence and Risk Factors: A Cross-sectional, Multicentre Study in a Population Aged 45 Years and Over in North-west Spain.</article-title>
            <source>Acta Derm Venereol</source>
            <year>2018</year>
            <month>Nov</month>
            <day>05</day>
            <volume>98</volume>
            <issue>10</issue>
            <fpage>970</fpage>
            <page-range>970-974</page-range>
            <pub-id pub-id-type="pmid">30085328</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17120.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Correa</surname>
                <given-names>GT</given-names>
              </name>
              <name>
                <surname>Bernardes</surname>
                <given-names>VF</given-names>
              </name>
              <name>
                <surname>de Sousa</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Diniz</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Salles</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Souza</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>De-Paula</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Gomez</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Gomes</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Lip cancer and pre-cancerous lesions harbor TP53 mutations, exhibit allelic loss at 9p, 9q, and 17p, but no BRAFV600E mutations.</article-title>
            <source>Tumour Biol</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>36</volume>
            <issue>11</issue>
            <fpage>9059</fpage>
            <page-range>9059-66</page-range>
            <pub-id pub-id-type="pmid">26084614</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17120.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Olinici</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cotrutz</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Mihali</surname>
                <given-names>CV</given-names>
              </name>
              <name>
                <surname>Grecu</surname>
                <given-names>VB</given-names>
              </name>
              <name>
                <surname>Botez</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Stoica</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Onofrei</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Condurache</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Dimitriu</surname>
                <given-names>DC</given-names>
              </name>
            </person-group>
            <article-title>The ultrastructural features of the premalignant oral lesions.</article-title>
            <source>Rom J Morphol Embryol</source>
            <year>2018</year>
            <volume>59</volume>
            <issue>1</issue>
            <fpage>243</fpage>
            <page-range>243-248</page-range>
            <pub-id pub-id-type="pmid">29940634</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17120.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carvalho</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>de Moraes</surname>
                <given-names>SLD</given-names>
              </name>
              <name>
                <surname>Lemos</surname>
                <given-names>CAA</given-names>
              </name>
              <name>
                <surname>Santiago J&#x000fa;nior</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Vasconcelos</surname>
                <given-names>BCDE</given-names>
              </name>
              <name>
                <surname>Pellizzer</surname>
                <given-names>EP</given-names>
              </name>
            </person-group>
            <article-title>Surgical versus non-surgical treatment of actinic cheilitis: A systematic review and meta-analysis.</article-title>
            <source>Oral Dis</source>
            <year>2019</year>
            <month>May</month>
            <volume>25</volume>
            <issue>4</issue>
            <fpage>972</fpage>
            <page-range>972-981</page-range>
            <pub-id pub-id-type="pmid">29908101</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17120.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benati</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pampena</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bombonato</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Borsari</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lombardi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Longo</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Dermoscopy and reflectance confocal microscopy for monitoring the treatment of actinic cheilitis with ingenol mebutate gel: Report of three cases.</article-title>
            <source>Dermatol Ther</source>
            <year>2018</year>
            <month>Jul</month>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>e12613</fpage>
            <pub-id pub-id-type="pmid">29687567</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17120.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pampena</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cornacchia</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pellacani</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Peris</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Longo</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Treatments of actinic cheilitis: A systematic review of the literature.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>83</volume>
            <issue>3</issue>
            <fpage>876</fpage>
            <page-range>876-887</page-range>
            <pub-id pub-id-type="pmid">31400450</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17120.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lugovi&#x00107;-Mihi&#x00107;</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pilipovi&#x00107;</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Crnari&#x00107;</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>&#x00160;itum</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Duvan&#x0010d;i&#x00107;</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Differential Diagnosis of Cheilitis - How to Classify Cheilitis?</article-title>
            <source>Acta Clin Croat</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>57</volume>
            <issue>2</issue>
            <fpage>342</fpage>
            <page-range>342-351</page-range>
            <pub-id pub-id-type="pmid">30431729</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
